Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2012 (2012), Article ID 364684, 12 pages
http://dx.doi.org/10.1155/2012/364684
Research Article

A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease

Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA

Received 8 December 2011; Revised 8 March 2012; Accepted 9 March 2012

Academic Editor: Carlos Barcia

Copyright © 2012 Shankar J. Chinta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shankar J. Chinta, Subramanian Rajagopalan, Abirami Ganesan, and Julie K. Andersen, “A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease,” Parkinson’s Disease, vol. 2012, Article ID 364684, 12 pages, 2012. doi:10.1155/2012/364684